Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z-S Chen

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Cancer Letters|June 23, 1999
An enhanced active efflux of CPT-11 and SN-38 in cisplatin-resistant human KB carcinoma cellsZ S Chen, T Sumizawa, T Furukawa, et al.
Biochemical and Biophysical Research Communications|July 30, 1997
Reversal of heavy metal resistance in multidrug-resistant human KB carcinoma cellsZ S Chen, M Mutoh, T Sumizawa, et al.
The Journal of International Medical Research|December 5, 2012
Optic atrophy differentially diagnosed as spinocerebellar ataxia from Leber hereditary optic neuropathy by gene mutation analysisY P Song, Z S Chen, G Y Mo, et al.
FEBS Letters|August 24, 1999
Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2)T Kawabe, Z S Chen, M Wada, et al.
Transplantation Proceedings|December 19, 2006
Experimental study on genistein prevention and treatment of transplant arteriosclerosis in aortic transplants of ratG C Zhu, Z Ding, Z S Chen, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|February 24, 2001
[Study on preparation and biodistribution of PEG-immunoliposomes with active carboxylic terminals]Y F Zhang, S S Xie, X P Hou, et al.
Molecular Pharmacology|April 30, 1999
ATP-Dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104PZ S Chen, T Furukawa, T Sumizawa, et al.
Lasers in Medical Science|August 15, 2016
Treatment of infraorbital dark circles using 694-nm fractional Q-switched ruby laserTian-Hua Xu, Yuan-Hong Li, John Z S Chen, et al.
Drugs of Today (Barcelona, Spain : 1998)|September 29, 2021
Pralsetinib for the treatment of non-small cell lung cancerX-Y Fu, X-D Dong, L Zeng, et al.
Drugs of Today (Barcelona, Spain : 1998)|June 21, 2021
Lurbinectedin for the treatment of small cell lung cancerL Li, C Zou, S Dong, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Cancer Letters|June 23, 1999
An enhanced active efflux of CPT-11 and SN-38 in cisplatin-resistant human KB carcinoma cellsZ S Chen, T Sumizawa, T Furukawa, et al.
Biochemical and Biophysical Research Communications|July 30, 1997
Reversal of heavy metal resistance in multidrug-resistant human KB carcinoma cellsZ S Chen, M Mutoh, T Sumizawa, et al.
The Journal of International Medical Research|December 5, 2012
Optic atrophy differentially diagnosed as spinocerebellar ataxia from Leber hereditary optic neuropathy by gene mutation analysisY P Song, Z S Chen, G Y Mo, et al.
FEBS Letters|August 24, 1999
Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2)T Kawabe, Z S Chen, M Wada, et al.
Transplantation Proceedings|December 19, 2006
Experimental study on genistein prevention and treatment of transplant arteriosclerosis in aortic transplants of ratG C Zhu, Z Ding, Z S Chen, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|February 24, 2001
[Study on preparation and biodistribution of PEG-immunoliposomes with active carboxylic terminals]Y F Zhang, S S Xie, X P Hou, et al.
Molecular Pharmacology|April 30, 1999
ATP-Dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104PZ S Chen, T Furukawa, T Sumizawa, et al.
Lasers in Medical Science|August 15, 2016
Treatment of infraorbital dark circles using 694-nm fractional Q-switched ruby laserTian-Hua Xu, Yuan-Hong Li, John Z S Chen, et al.
Drugs of Today (Barcelona, Spain : 1998)|September 29, 2021
Pralsetinib for the treatment of non-small cell lung cancerX-Y Fu, X-D Dong, L Zeng, et al.
Drugs of Today (Barcelona, Spain : 1998)|June 21, 2021
Lurbinectedin for the treatment of small cell lung cancerL Li, C Zou, S Dong, et al.
Pageof 8